China: Venus Medtech to partner with Haoyue Group on heart implants

Hangzhou-based, transcatheter heart valve company Venus Medtech has set up a joint venture company with Haoyue Group to develop high-end cardiovascular disease implant devices. Venus Haoyue Medtech will design artificial biological heart valves, including aortic, pulmonary, mitral and tricuspid valves, for surgical implantation and other biological patches. At the moment, imported biological valves account for…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »